GEMO, a National Resource to Study Genetic Modifiers of Breast and Ovarian Cancer Risk in BRCA1 and BRCA2 Pathogenic Variant Carriers.
Fabienne Lesueur,Noura Mebirouk,Yue Jiao,Laure Barjhoux,Muriel Belotti, Maïté Laurent,Mélanie Léone,Claude Houdayer,Brigitte Bressac-de Paillerets,Dominique Vaur,Hagay Sobol,Catherine Noguès,Michel Longy,Isabelle Mortemousque,Sandra Fert-Ferrer,Emmanuelle Mouret-Fourme,Pascal Pujol,Laurence Venat-Bouvet,Yves-Jean Bignon,Dominique Leroux,Isabelle Coupier,Pascaline Berthet,Véronique Mari,Capucine Delnatte,Paul Gesta,Marie-Agnès Collonge-Rame,Sophie Giraud,Valérie Bonadona,Amandine Baurand,Laurence Faivre,Bruno Buecher,Christine Lasset,Marion Gauthier-Villars,Francesca Damiola,Sylvie Mazoyer,Sandrine M Caputo,Nadine Andrieu,Dominique Stoppa-Lyonnet FRONTIERS IN ONCOLOGY（2018）
摘要
DATA REPORT article Front. Oncol., 31 October 2018Sec. Cancer Genetics Volume 8 - 2018 | https://doi.org/10.3389/fonc.2018.00490
更多查看译文
关键词
breast cancer,BRCA1/2 mutation carriers,pathogenic variant (PV),DNA banking,genetic epidemiology
AI 理解论文
溯源树
样例
